Top Markets
Coin of the day
Inari Medical, Inc. Inari Medical, Inc.

Inari Medical, Inc.

NARI
Classifica tra le azioni #3846
Inari Medical, Inc. is a medical technology firm focused on creating,... Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
Prezzo delle azioni
$79.97
Ultima sincronizzazione: 2025-02-19
Capitalizzazione di mercato
$4.57B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Inari Medical, Inc. (NARI)

Categoria

Rapporto P/S per Inari Medical, Inc. (NARI)
Rapporto P/S al August 2026 TTM: 9.49
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Inari Medical, Inc., il rapporto P/S attuale (TTM) è 9.49. Alla fine del 2022, era pari a 8.76.
Storico del rapporto P/S per Inari Medical, Inc. da 2018 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
2026 (TTM) 9.49 27.01%
2023 7.47 -14.75%
2022 8.76 -46.65%
2021 16.42 -18.01%
2020 20.02 -50.02%
2019 40.06 -85.68%
2018 279.83 0.00%
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
4.13 -56.44%
US
5.03 -46.95%
US
2.78 -70.65%
IE
3.67 -61.33%
US
- -
DE